Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fg-2101
2. 2919723-66-1
3. Schembl29244972
4. Gtpl13854
5. Ex-a12464
6. At48492
7. (s)-4-(3-(3-cyanoazetidin-1-yl)-2-(4-((4-(morpholinomethyl)phenyl)ethynyl)phenyl)propyl)-6-oxo-1,6-dihydropyrimidin-5-yl Dihydrogen Phosphate
8. [4-[(2s)-3-(3-cyanoazetidin-1-yl)-2-[4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]phenyl]propyl]-6-oxo-1h-pyrimidin-5-yl] Dihydrogen Phosphate
| Molecular Weight | 589.6 g/mol |
|---|---|
| Molecular Formula | C30H32N5O6P |
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 148 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1180 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
70
PharmaCompass offers a list of FG-2101 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right FG-2101 manufacturer or FG-2101 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred FG-2101 manufacturer or FG-2101 supplier.
A FG-2101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FG-2101, including repackagers and relabelers. The FDA regulates FG-2101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FG-2101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A FG-2101 supplier is an individual or a company that provides FG-2101 active pharmaceutical ingredient (API) or FG-2101 finished formulations upon request. The FG-2101 suppliers may include FG-2101 API manufacturers, exporters, distributors and traders.
FG-2101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FG-2101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right FG-2101 GMP manufacturer or FG-2101 GMP API supplier for your needs.
A FG-2101 CoA (Certificate of Analysis) is a formal document that attests to FG-2101's compliance with FG-2101 specifications and serves as a tool for batch-level quality control.
FG-2101 CoA mostly includes findings from lab analyses of a specific batch. For each FG-2101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FG-2101 may be tested according to a variety of international standards, such as European Pharmacopoeia (FG-2101 EP), FG-2101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FG-2101 USP).
